Drugs / Recombinant FVIII
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00612417 | Jan → Mar 2008 | — | ThromboGenics | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01064284 Comparator | Jan 2010 → May 2015 | hemophilia A | Fondazione Angelo Bianchi Bonomi | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Recombinant FVIII | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01064284 ↗ |
| Known as | recombinant human Factor VIII | “A Randomised, Double-blind and Placebo-controlled Study Investigating the Pharmacodynamic Effects of Administration of Recombinant Human Factor VIII in Healthy Male Subjects...” NCT00612417 ↗ |
| Modality | Protein / enzyme biologic | “Administration of Recombinant Human Factor VIII” NCT00612417 ↗ |